News summaryInvestor's Business DailyNov 16, 2026, 02:57 PM
FDA Rejects Summit's China-Developed Merck Rival; Shares Dive
MRKequity_markets
FDA Rejects Summit's China-Developed Merck Rival; Shares Dive Investor's Business Daily
Loading...
FDA Rejects Summit's China-Developed Merck Rival; Shares Dive Investor's Business Daily